TURBO CANCER Literature is growing rapidly - 6 new COVID-19 Vaccine Turbo Cancer papers published in April 2024 - 26 total
https://makismd.substack.com/p/turbo-cancer-literature-is-growing
TURBO CANCER LITERATURE (15 papers/preprints):
(2024 Apr, Zhang and El-Deiry) - SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells
https://www.biorxiv.org/content/10.1101/2024.04.12.589252v1
(2024 Apr, Rubio-Casillas et al) - Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
https://pubmed.ncbi.nlm.nih.gov/38583833/
(2024 Apr, Gibo et al) - Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/
(2023 Dec, Angues et al) - SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis
https://pubmed.ncbi.nlm.nih.gov/38234925/
(2023 Nov, Patrick Chambers) - The CD147 Epitope on SARS CoV2 and the Spike in Cancer, Autoimmunity and Organ Fibrosis
https://www.researchgate.net/publication/375312458_The_CD147_Epitope_on_SARS_CoV2_and_the_Spike_in_Cancer_Autoimmunity_and_Organ_Fibrosis/fulltext/65465084b1398a779d5b0a1d/The-CD147-Epitope-on-SARS-CoV2-and-the-Spike-in-Cancer-Autoimmunity-and-Organ-Fibrosis.pdf
(2023 Oct, Speicher et al) - DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.
https://osf.io/xv3nz/
(2023 Sep, McKernan et al) - Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose
https://www.researchgate.net/publication/369967228_Sequencing_of_bivalent_Moderna_and_Pfizer_mRNA_vaccines_reveals_nanogram_to_microgram_quantities_of_expression_vector_dsDNA_per_dose
(2023 May, Uversky, Redwan, Makis, Rubio-Casillas) - IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
https://pubmed.ncbi.nlm.nih.gov/37243095/
(2023 May, Eens et al) - B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/
(2023 Apr, Halma, Rose, Lawrie) - The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
https://www.mdpi.com/2571-8800/6/2/17
(2023 March, Guetzkow et al) - National Academies Committee on Review of Relevant Literature Regarding Adverse Events Associated with Vaccines
https://nationalcitizensinquiry.b-cdn.net/wp-content/uploads/2023/09/VT-3tt-Makis-Wiseman-06b-Turbo-Cancer-Paper16-Wiseman.pdf
(2022 May, Jiang et al) - SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (Retracted)
https://pubmed.ncbi.nlm.nih.gov/34696485/
(2022 Apr, Seneff et al) - Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
https://pubmed.ncbi.nlm.nih.gov/35436552/
(2022 Feb, Alden et al) - Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
https://pubmed.ncbi.nlm.nih.gov/35723296/
(2020 Oct, Singh) - S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study
https://pubmed.ncbi.nlm.nih.gov/32619819/
p1